# Patient-Oriented Priorities for Pediatric Erythromelalgia: A Priority-Setting Process

**Authors:** Don Daniel Ocay, Meghan Halpin, Ella Ford, Karen Keighley, Neva Keighley, Nikki Ramsay, Tayla Ramsay, Camelia M. Sheridan, Sarah M. Sheridan, Kirsten R. Tice, Deirdre De Ranieri, See Wan Tham, Catherine A. Brownstein, Jacqui Clinch, Dawn Marie Davis, Carolina Donado, Genevieve D’Souza, Deepa Kattail, Kimberly Lobo, Danielle Ravetti, Paola Sandroni, Jennifer N. Stinson, Gary A. Walco, Suellen M. Walker, Timothy W. Yu, Charles B. Berde

PMC · DOI: 10.3390/children12111477 · 2025-11-02

## TL;DR

This study identifies the top 10 research priorities for pediatric erythromelalgia from the perspectives of patients, families, and clinicians.

## Contribution

It presents the first international patient-centered research agenda for childhood-onset erythromelalgia.

## Key findings

- The top priorities focused on treatment, underlying mechanisms, and associations with body systems.
- The final list was developed through a consensus process involving participants from multiple countries.
- The study highlights the need for improved research and care for pediatric erythromelalgia.

## Abstract

Background/Objectives: Erythromelalgia is a rare condition characterized by burning pain, redness, and warmth primarily in the extremities, usually worsened by heat and alleviated by cold. The objective of this study was to identify the top 10 priorities in pediatric erythromelalgia from multiple perspectives, including clinicians, people with lived experience of childhood-onset erythromelalgia, and their family members. Methods: A modified James Lind Alliance Priority-Setting Process was conducted. The top priorities were identified through four phases: (1) an international online survey to gather priorities, (2) data processing, (3) an interim prioritization online survey, and (4) a virtual workshop to set the final priorities. Results: In phase 1, 185 potential priorities were submitted by 74 respondents (53% patients, 24% family members, and 23% clinicians) that were developed into 68 unique research questions (phase 2). In phase 3, of the 68 questions, 50 were rated for importance by 58 participants (38% patients, 36% family members, and 26% clinicians), reducing the list to 25 questions. In phase 4, the top 10 was reached through consensus by 12 participants (33% patients, 25% family members, and 42% clinicians) across Canada, South Africa, the United States of America, and the United Kingdom. Conclusions: The final priorities focused on the treatment of erythromelalgia, understanding underlying mechanisms, the association of erythromelalgia with various body systems, and generating awareness. This list is the first international patient-centered research agenda for childhood-onset erythromelalgia and a call to action from key partners to improve future research and care.

## Linked entities

- **Diseases:** erythromelalgia (MONDO:0016028)

## Full-text entities

- **Diseases:** Erythromelalgia (MESH:D004916), pain (MESH:D010146)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12650981/full.md

---
Source: https://tomesphere.com/paper/PMC12650981